Clinical Trials
Boston Biomedical Announces Unblinding of the Phase 3 Trial in Patients with Advanced Gastric/GEJ Cancer
Boston Biomedical Inc, Â announced that the BRIGHTER Trial evaluating the efficacy and safety of napabucasin plus paclitaxel versus paclitaxel alone for patients with advanced gastric/GEJ (gastroesophageal junction) cancer will be unblinded. This decision is based on...
Clinical Trials
OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers
OncoArendi Therapeutics SA announced that it has selected OATD‑02 as its clinical development candidate for cancer immunotherapy. Submission of the Company's second Investigational New Drug ("IND") application is expected by the third quarter of 2018. OATD-02...
Clinical Trials
goBalto and Informa Partner to Accelerate Site Selection for Global Clinical Trials
goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, announced its partnership with Citeline, part of Informa's Pharma Intelligence vertical, to integrate data from Citeline's intelligence platforms — including Trialtrove and Sitetrove — with goBalto's Select....
Clinical Trials
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide
Astellas Pharma Inc and Pfizer Inc announced the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of XTANDI in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC)....
Clinical Trials
HedgePath Pharma Announces granting of Type-C meeting request by FDA and provides positive clinical trial update
HedgePath Pharmaceuticals, Inc , a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. Announced the grant of a Type-C Guidance Meeting Request by the U.S. FDA concerning further guidance...
Clinical Trials
KUKA Medical Robotics at the CMEF in Shanghai:Â robots assist surgeons dur-ing operations
KUKA is showcasing the possibilities of using sensitive robots to support doc-tors at the flagship show for the medical technology sector, China International Medical Equipment Fair (CMEF) in Shanghai from 15 to 18 May 2017 Â ...
Clinical Trials
AstraZeneca Imfinzi significantly reduces the risk of disease in the Phase III PACIFIC trial for lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm announced positive results for the Phase III PACIFIC trial, a randomised. Double-blinded, placebo-controlled multi-centre trial of Imfinzi (durvalumab) as sequential treatment in patients with locally-advanced, unresectable...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
